Rigel Pharmaceuticals RIGL Finite Lived Intangible Assets Amortization Expense After Year Five
Finite Lived Intangible Assets Amortization Expense After Year Five at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's finite lived intangible assets amortization expense after year five.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's finite lived intangible assets amortization expense after year five?
- Rigel Pharmaceuticals (RIGL) reported finite lived intangible assets amortization expense after year five of $12.99M in Q4 2025.